Access cutting-edge sars- cov-2 treatment through this clinical trial at a research site in Columbia. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Columbia location
Preparing your pre-screening questions…
Access sars- cov-2 specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sars- cov-2 treatment provided free
Check if you qualify for this sars- cov-2 clinical trial in Columbia, SC
No-Cost Study Care
Local to Columbia
Convenient for SC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.
Sponsor: University of South Carolina
Yes, this clinical trial (NCT05370014) has an active research site in Columbia, SC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for sars- cov-2 treatment options in Columbia, SC, this clinical trial (NCT05370014) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sars- cov-2 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.